Schedule 13D ownership disclosure

INOTEK PHARMACEUTICALS CORP

Security class unavailable · CUSIP: 45780V102

Event date: 2017-01-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-17-000026
Form type
SC 13D/A
Filer
DEVON PARK BIOVENTURES LP
CIK
CIK 1356034
Filed
Jan 06, 2017
Reporting period
Jan 04, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub